Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Jun 14;103(24):e38298.
doi: 10.1097/MD.0000000000038298.

Primary diffuse large B-cell lymphoma of adrenal gland: A case report

Affiliations
Case Reports

Primary diffuse large B-cell lymphoma of adrenal gland: A case report

Yong Ou et al. Medicine (Baltimore). .

Abstract

Introduction: Most adrenal tumors are benign and primary adrenal malignancies are relatively rare. Primary adrenal lymphoma (PAL) is a very rare and highly aggressive malignant tumor with unknown etiology, atypical clinical symptoms, nonspecific imaging manifestations, difficult disease diagnosis and poor prognosis.

Case report: This case report details a 42-year-old woman who was admitted to the hospital with a 1-year-old bilateral adrenal mass and 1-month-old left upper abdominal pain. Enhanced CT of the abdomen showed a right adrenal nodule and a large occupying lesion in the left adrenal region, with a high probability of pheochromocytoma. Intraoperatively, a huge tumor measuring about 12*12*10 cm was found in the left adrenal region, infiltrating the left kidney, spleen and pancreatic tail. Postoperative pathology: lymphocytes were found in the renal capsule and subcapsule, lymphocytes were found in the pancreas; lymphocytes were found in the spleen. Consider a tumor of the lymphohematopoietic system, possibly lymphoma.

Conclusion: This case demonstrates that primary adrenal diffuse large B-cell lymphoma (PADLBCL) is highly aggressive, has a poor prognosis, is prone to recurrence, has poor therapeutic outcomes, and is difficult to diagnose. Clinicians should consider the possibility of PADLBCL when encountering huge adrenal-occupying lesions and consider chemotherapy before surgery. Reducing the tumor size before surgery is a more favorable therapeutic approach, thus prolonging the patient life and improving the quality of survival.

PubMed Disclaimer

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
(A and B) Abdominal enhanced CT showed that the right adrenal nodule and the left adrenal region were huge space-occupying lesions, and pheochromocytoma was possible. (C) Postoperative adrenal tumor. (D) Pathological section after operation showed lymphoma.

Similar articles

References

    1. Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology (Phila). 2018;50:74–87. - PubMed
    1. Grigg AP, Connors JM. Primary adrenal lymphoma. Clin Lymphoma. 2003;4:154–60. - PubMed
    1. Abaroa-Salvatierra A, Shaikh B, Deshmukh M, et al. . Calcitriol-mediated hypercalcemia in a patient with bilateral adrenal non-Hodgkin’s B-cell lymphoma case report. J Community Hosp Intern Med Perspect. 2016;6:30381. - PMC - PubMed
    1. Ellis RD, Read D. Bilateral adrenal non-Hodgkin’s lymphoma with adrenal insufficiency. Postgrad Med J. 2000;76:508–9. - PMC - PubMed
    1. Wang Y, Ren Y, Ma L, et al. . Clinical features of 50 patients with primary adrenal lymphoma. Front Endocrinol (Lausanne). 2020;11:595. - PMC - PubMed

Publication types

MeSH terms